By Mill Chart
Last update:
Finding undervalued stocks can be a rewarding strategy for investors looking for long-term growth opportunities. These stocks trade below their intrinsic value, offering potential upside as the market corrects its pricing. One such candidate is Universal Health Services-B (NYSE:UHS), a healthcare provider with strong fundamentals and an attractive valuation.
Universal Health Services-B (NYSE:UHS) operates acute care hospitals and behavioral health facilities across the U.S. and internationally. The company has demonstrated consistent profitability, solid growth, and reasonable financial health—key factors that make it appealing for value investors.
The company earns a Profitability Rating of 7/10, reflecting healthy margins and efficient capital use. Its Return on Assets (8.05%) and Return on Equity (17.64%) outperform most industry peers, indicating effective management and strong earnings generation.
With a Valuation Rating of 9/10, Universal Health Services-B appears undervalued. Its Price/Earnings ratio of 9.96 is significantly lower than both the industry average (38.92) and the S&P 500 (28.88). Additionally, its Price/Forward Earnings ratio of 8.25 suggests further upside potential.
The company maintains a Growth Rating of 6/10, supported by a 49.29% year-over-year EPS increase and steady revenue expansion. Analysts project continued earnings growth at 12.93% annually, reinforcing its long-term potential.
While its Health Rating of 5/10 indicates some financial caution, Universal Health Services-B maintains manageable debt levels and sufficient liquidity. The company has reduced shares outstanding over time, improving shareholder value.
Universal Health Services-B (NYSE:UHS) presents a compelling case for value investors. Its strong profitability, low valuation, and stable growth make it a noteworthy candidate. For a detailed breakdown, review the full fundamental analysis report.